Co-Authors
This is a "connection" page, showing publications co-authored by Xiaolong Qi and Xiaozhong Guo.
Connection Strength
1.400
-
Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure. Dig Liver Dis. 2021 09; 53(9):1069-1070.
Score: 0.237
-
Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study. Medicine (Baltimore). 2021 May 14; 100(19):e25497.
Score: 0.236
-
Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests. Ann Hepatol. 2021 Sep-Oct; 24:100349.
Score: 0.235
-
Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: a systematic review and meta-analysis. Ann Palliat Med. 2021 May; 10(5):5069-5083.
Score: 0.235
-
Clinical characteristics and outcomes of COVID-19 patients with hypoxic hepatitis. Clin Res Hepatol Gastroenterol. 2021 Mar; 45(2):101665.
Score: 0.233
-
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatol Int. 2020 Sep; 14(5):621-637.
Score: 0.223